5 terminated. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
| Phase 2 | 2 | Terminated 2 |
Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. Clonidine HCl Mucoadhesive Buccal Tablet, Placebo Mucoadhesive Buccal Tablet - Chemoradiotherapy-Induced Severe Oral Mucositis | Phase 2 / Phase 3 | Terminated | Monopar Therapeutics | 190 | 2021-02-11 | 2023-05-31 |
| Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy Caphosol, Biotene - Oral Mucositis | Phase 3 | Terminated | Medical College of Wisconsin | 1 | 2016-10-01 | 2020-03-09 |
| Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer Homeodent®, 1.4% Sodium Bicarbonate solution - Oropharynx Cancer, Hypopharynx Cancer | Phase 3 | Terminated | Centre Leon Berard | 78 | 2009-05-01 | 2012-11-01 |
| EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer EN3285, Placebo, Standard of care - Oral Mucositis, Head and Neck Cancer | Phase 3 | Terminated | Endo USA Inc., a Keenova Therapeutics Company | 240 | 2007-12-01 | 2013-09-20 |
| Lamictal in the Treatment of Post-Herpetic Neuralgia Lamictal in the treatment of Post-Herpetic Neuralgia - Neuralgia, Postherpetic | Phase 2 / Phase 3 | Terminated | George Washington University | 2005-02-01 | 2013-03-13 |
Head and Neck Neoplasms (2) · Oropharyngeal Neoplasms (2) · Carcinoma, Squamous Cell (1) · Hypopharyngeal Neoplasms (1) · Mucositis (1) · Neoplasms (1) · Neuralgia, Postherpetic (1) · Oral Ulcer (1) · Stevens-Johnson Syndrome (1)
Mouth Diseases (5) · Stomatognathic Diseases (5) · Neoplasms (3) · Neoplasms by Site (3) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Carcinoma (1) · Chemically-Induced Disorders (1) · Dermatitis (1) · Digestive System Diseases (1) · Drug Eruptions (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1)
Biotene (1) · Lamotrigine (1) · Saliva, Artificial (1) · Standard of Care (1)
Centre Leon Berard (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · George Washington University (1) · Medical College of Wisconsin (1) · Monopar Therapeutics (1)
United States (4) · France (2) · Germany (1) · Puerto Rico (1) · Spain (1)
Holli Carlson (1) · Mark Chambers, MD (1) · Michael E Burke, MD (1) · Perry K. Richardson, M.D. (1)